(Total Views: 593)
Posted On: 02/03/2020 4:55:41 PM
Post# of 151
$MRK News Article - FDA Accepts For Review Supplemental New Drug Application (sNDA) for RECARBRIO(TM) (imipenem, cilastatin, and relebactam) for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) https://marketwirenews.com/news-releases/fda-...29722.html
(0)
(0)
My Twitter: WhyteStocks
